No profile data available.
Cryoport, Inc. (CYRX) is a manufacturing and production company in the distribution management companies industry, based in Brentwood, United States, with about 684 full-time employees.
It reported revenue of $176.18 million for fiscal year 2025, down 22.9% from fiscal year 2024, and net income of $70.30 million. Its largest business segment, Life Sciences Services, brought in 57% of segment revenue in fiscal year 2025; Americas was the largest region with 75%. Its market capitalization was $878.76 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry.
Cryoport reported $176.18 million in revenue for fiscal year 2025, down 22.9% from $228.39 million in fiscal year 2024.
Life Sciences Services, with $102.15 million or 57% of segment revenue in fiscal year 2025. Next: Life Sciences Products (43%).
Americas: 75% of revenue by region in fiscal year 2025, followed by Europe, The Middle East and Africa (14%).
$878.76 million as of October 9, 2026.
Listed companies of a similar size in the same industry (distribution management companies) include GXO Logistics, Inc. (GXO), Rxo, Inc. (RXO), Qudian Inc. (QD), ContextLogic Holdings Inc. (LOGC).